Drug sales in Russia steadily grow this year

9 November 2017
russia_moscow_large-1-

Drug sales in Russia are steadily growing this year, according to latest data of the Russian Ministry of Health, reports The Pharma Letter’s local correspondent.

For the 9 months of the current year drug sales in Russia grew by 13.7% on year-on-year basis to 3.3 billion packs in value terms.

In value terms, the growth in sales was equivalent to 13.3%. The majority of sales accounted for drugs against cold-related diseases and viruses.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical